Unpredictable and politically driven regulatory approaches cultivate an environment of enormous uncertainty for vaccine ...

The Drug Enforcement Administration is under growing scrutiny for alleged ethical violations, constitutional defiance, and obstruction of marijuana research, prompting calls for mass terminations, ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer application for approval.

McKesson Corp. has announced plans to separate its Medical-Surgical Solutions segment into an independent company. This strategic move is aimed at sharpening McKesson’s focus on higher-growth, higher- ...

The presentation details are as follows: Abstract Title: Reduction in Annualized Exacerbations with Rademikibart in Eosinophilic Driven, Type 2 Asthma Abstract Number: 001671 Presenter: Rekha ...

There's no reason the U.S. can't pick up the pace to match the global clinical research front-runners without compromising ...

Cold chain monitoring solutions have become indispensable to the biopharma business for managing complicated supply chains.

The pharma giant is betting that Blueprint, whose research revolves around a certain kind of tyrosine kinase, will be a boost ...

Sanofi has entered into an agreement to acquire Blueprint Medicines Corp., a U.S.-based biopharma company specializing in ...

The CDMO's head of development talks about ADCs, accelerated timelines, and the push for end-to-end development services.

French drugmaker Sanofi said Monday it has agreed to acquire Blueprint Medicines for $9.5 billion, sending shares of the ...